Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

Kyowa Kirin Plans $530 Million Biologic Manufacturing Plant in US

publication date: Jun 11, 2024

Tokyo’s Kyowa Kirin will invest up to $530 million to build a biologics manufacturing plant in Sanford, North Carolina, an area known as The Research Triangle. The facility will be a 15,951 square meter (171,700-square-foot), two-bioreactor facility that is scheduled to break ground in Q3 of 2024. Kyowa Kirin said the new facility will accelerate the development and production of biologic therapies for patients with debilitating diseases that have unmet medical needs. The company’s research interests include next-gen antibodies, small molecule drugs, nucleic acid drugs and regenerative medicine products. Kyowa Kirin already has two manufacturing facilities in Japan. More details....

Stock Symbol: (TSE: 4151)

Share this with colleagues:  


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

Upcoming Events

ChinaBio® Partnering Forum
September 10–11, 2024 | Shanghai, China
Register here

BIO-Europe®
November 4–6, 2024 | Stockholm, Sweden
Save €900 before September 13!
Register here

Biotech Showcase™
January 13–15, 2025 | San Francisco, CA
Save $600 before September 27!
Other Relevant Events

Antibody Engineering & Therapeutics Asia
October 21–23, 2024 | Kyoto, Japan
Save 30% with code CHINABIO30!
Register here